Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-assisted evaluation of antibiotic regimen coverage and cost.

D Day1, T J Lubowski, C C Yamaga

  • 1Pfizer Pharmaceuticals Group, Pfizer Inc, New York, New York 10017, USA.

Clinical Therapeutics
|September 15, 1999
PubMed
Summary

Dare to Compare 98 is a computer program that simplifies antibiotic regimen evaluation for healthcare professionals. It analyzes cost-effectiveness using local data to optimize treatment choices for infectious diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Measurements of the Deuteron-to-Proton F_{2} Structure-Function Ratio.

Physical review letters·2025
Same author

Novel Measurement of the Neutron Magnetic Form Factor from A=3 Mirror Nuclei.

Physical review letters·2024
Same author

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.

ESMO open·2023
Same author

Revealing the short-range structure of the mirror nuclei <sup>3</sup>H and <sup>3</sup>He.

Nature·2022
Same author

Ruling out Color Transparency in Quasielastic ^{12}C(e,e^{'}p) up to Q^{2} of 14.2  (GeV/c)^{2}.

Physical review letters·2021
Same author

Probing the Deuteron at Very Large Internal Momenta.

Physical review letters·2021

Area of Science:

  • Pharmacoeconomics
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Evaluating antibiotic regimens for cost-effectiveness is crucial for drug selection.
  • Current evaluations can be complex, time-consuming, and misleading if not based on local data.

Purpose of the Study:

  • To introduce Dare to Compare 98, a computer program designed for analyzing empiric antibiotic regimens.
  • To assist pharmacists and physicians in selecting optimal antibiotic treatments.

Main Methods:

  • The program incorporates an Infectious Disease Challenge to identify common pathogens.
  • It generates Antibiogram Susceptibility Reports using local or comparable national data.
  • Susceptibility data is integrated with cost data in the Quality/Cost Index.

Related Experiment Videos

Main Results:

  • Dare to Compare 98 combines susceptibility and cost data to create a Quality/Cost Index.
  • Users can determine optimal microbiologic activity and cost-effective regimens based on local data.

Conclusions:

  • Dare to Compare 98 facilitates efficient evaluation of antibiotic regimens.
  • The program aids in selecting suitable treatments for formularies and disease-management algorithms.